Collateral for a security interest recorded Mar 16, 2026 (Symbiotic Capital Agency LLC).
Term ends Jan 28, 2029 · High confidence
20-year base term ends Jan 28, 2029
Held by Vero Biotech Inc.
Filed Dec 16, 2013 as application 14/107,535 · Granted Jun 3, 2014
Base term, 20 years from filing
Today
2009
2029
Clock starts
Jan 28, 2009
Jan 28, 2009
Term ends
Jan 28, 2029
Jan 28, 2029
Granted
Jun 3, 2014
Jun 3, 2014
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,914,743, to Jan 28, 2029. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 28, 2009, when application 12/361,274, the earliest non-provisional in its chain, was filed (this one was filed Dec 16, 2013) | Jan 28, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,914,743) | resolves to Jan 28, 2029, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 28, 2029 | High confidence |
This family
| US 7,914,743 | In force Jun 2029 | Jun 2029 |
| Application PCT/US2009/032254 | PCT application no patent term | no patent term |
| US 8,187,544 | In force Jan 2029 | Jan 2029 |
| US 8,609,026 | In force Jan 2029 | Jan 2029 |
| US 8,741,222 | this patent Jan 2029 | Jan 2029 |
| US 9,701,538 | In force Jan 2029 | Jan 2029 |
| US 10,081,544 | In force Jan 2029 | Jan 2029 |
| Application 16/140,497 | Abandoned not computed | not computed |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 19, 2013 Reel 31817, frame 371 | Fine, David H.; Vasquez, Gregory; Rounbehler, David P. | Geno LLC | Assignment of Assignor's Interest |
| Jun 6, 2018 Reel 46304, frame 855 | Geno LLC | Vero Biotech LLC | Change of Name |
| Dec 29, 2020 Reel 54866, frame 589 | Vero Biotech LLC | Runway Growth Credit Fund Inc. | Security Interest |
| Feb 14, 2022 Reel 59085, frame 418 | Vero Biotech LLC | Vero Biotech Inc. | Change of Name |
| Jan 3, 2024 Reel 66186, frame 611 | Runway Growth Finance Corp. (F/K/A Runway Growth Credit Fund Inc.) | Vero Biotech Inc. (F/K/A Vero Biotech LLC) | Termination and Release of Intellectual Property Security Agreement |
| Jan 3, 2024 Reel 66187, frame 865 | Vero Biotech Inc. | Horizon Technology Finance Corporation | Security Interest |
| Mar 16, 2026 Reel 75117, frame 935 | Vero Biotech Inc. | Symbiotic Capital Agency LLC, as Collateral Agent | Security Interest |
| Mar 18, 2026 Reel 75308, frame 198 | Horizon Technology Finance Corporation | Vero Biotech Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2029
Term ends Jan 28, 2029. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,914,743, ends no earlier than this term, so it caps nothing.
Citations
26
later US patents cite this one
That is top 25% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.